Dixon Hughes Goodman Wealth Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Dixon Hughes Goodman Wealth Advisors's NVS Position: Q1 2022 in Review
Dixon Hughes Goodman Wealth Advisors increased its Novartis (NVS) stake by 4.9% in Q1 2022, buying an estimated $1.56K and bringing the position to 385 shares worth $34K. The position accounts for 0.01% of the portfolio, ranked #360.
Dixon Hughes Goodman Wealth Advisors first reported a position in NVS in Q4 2021 and has held it in 2 quarters since. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.
- Dixon Hughes Goodman Wealth Advisors held 385 shares of Novartis worth $34K as of Q1 2022.
- Dixon Hughes Goodman Wealth Advisors bought 18 Novartis shares in Q1 2022, an estimated $1.56K.
- Novartis made up 0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #360 holding.
- Dixon Hughes Goodman Wealth Advisors first reported a position in Novartis in Q4 2021 and has held it in 2 quarters since.
- 1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.
Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.